Literature DB >> 31534238

Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity.

Nathan W Zammit1,2, Owen M Siggs1,3, Christopher C Goodnow4,5, Shane T Grey6,7, Paul E Gray8,9, Keisuke Horikawa10, David B Langley1,2, Stacey N Walters1,2, Stephen R Daley10,11, Claudia Loetsch1, Joanna Warren1,2, Jin Yan Yap1, Daniele Cultrone1,2, Amanda Russell1, Elisabeth K Malle1, Jeanette E Villanueva1, Mark J Cowley1,2, Velimir Gayevskiy1, Marcel E Dinger1,12, Robert Brink1,2, David Zahra1,2, Geeta Chaudhri10,13, Gunasegaran Karupiah10,14, Belinda Whittle10, Carla Roots10, Edward Bertram10, Michiko Yamada10, Yogesh Jeelall10, Anselm Enders10, Benjamin E Clifton15, Peter D Mabbitt15, Colin J Jackson15, Susan R Watson16, Craig N Jenne16,17, Lewis L Lanier16, Tim Wiltshire18, Matthew H Spitzer19,20, Garry P Nolan19, Frank Schmitz21,22, Alan Aderem21, Benjamin T Porebski11, Ashley M Buckle11, Derek W Abbott23, John B Ziegler8,9, Maria E Craig9,24, Paul Benitez-Aguirre24, Juliana Teo24, Stuart G Tangye1,2, Cecile King1,2, Melanie Wong24, Murray P Cox25, Wilson Phung26, Jia Tang26, Wendy Sandoval26, Ingrid E Wertz26, Daniel Christ1,2.   

Abstract

Resisting and tolerating microbes are alternative strategies to survive infection, but little is known about the evolutionary mechanisms controlling this balance. Here genomic analyses of anatomically modern humans, extinct Denisovan hominins and mice revealed a TNFAIP3 allelic series with alterations in the encoded immune response inhibitor A20. Each TNFAIP3 allele encoded substitutions at non-catalytic residues of the ubiquitin protease OTU domain that diminished IκB kinase-dependent phosphorylation and activation of A20. Two TNFAIP3 alleles encoding A20 proteins with partial phosphorylation deficits seemed to be beneficial by increasing immunity without causing spontaneous inflammatory disease: A20 T108A;I207L, originating in Denisovans and introgressed in modern humans throughout Oceania, and A20 I325N, from an N-ethyl-N-nitrosourea (ENU)-mutagenized mouse strain. By contrast, a rare human TNFAIP3 allele encoding an A20 protein with 95% loss of phosphorylation, C243Y, caused spontaneous inflammatory disease in humans and mice. Analysis of the partial-phosphorylation A20 I325N allele in mice revealed diminished tolerance of bacterial lipopolysaccharide and poxvirus inoculation as tradeoffs for enhanced immunity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31534238     DOI: 10.1038/s41590-019-0492-0

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  1 in total

1.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent.

Authors:  S KIBRICK; K BENIRSCHKE
Journal:  Pediatrics       Date:  1958-11       Impact factor: 7.124

  1 in total
  17 in total

Review 1.  The genetic and evolutionary determinants of COVID-19 susceptibility.

Authors:  Gaspard Kerner; Lluis Quintana-Murci
Journal:  Eur J Hum Genet       Date:  2022-06-28       Impact factor: 5.351

2.  The genomic signatures of natural selection in admixed human populations.

Authors:  Sebastian Cuadros-Espinoza; Guillaume Laval; Lluis Quintana-Murci; Etienne Patin
Journal:  Am J Hum Genet       Date:  2022-03-07       Impact factor: 11.043

Review 3.  Necrotic reshaping of the glioma microenvironment drives disease progression.

Authors:  Steven M Markwell; James L Ross; Cheryl L Olson; Daniel J Brat
Journal:  Acta Neuropathol       Date:  2022-01-17       Impact factor: 15.887

4.  A20 as an immune tolerance factor can determine islet transplant outcomes.

Authors:  Nathan W Zammit; Stacey N Walters; Karen L Seeberger; Philip J O'Connell; Gregory S Korbutt; Shane T Grey
Journal:  JCI Insight       Date:  2019-11-01

Review 5.  Pathway paradigms revealed from the genetics of inflammatory bowel disease.

Authors:  Daniel B Graham; Ramnik J Xavier
Journal:  Nature       Date:  2020-02-26       Impact factor: 49.962

Review 6.  Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents.

Authors:  Rui Xue Zhang; Franky Fuh-Ching Liu; Hoyin Lip; Junhong Liu; Qianrong Zhang; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2022-01-22       Impact factor: 5.671

Review 7.  Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.

Authors:  Tanuza Das; Sang Chul Shin; Eun Joo Song; Eunice EunKyeong Kim
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

8.  A zebrafish functional genomics model to investigate the role of human A20 variants in vivo.

Authors:  Daniele Cultrone; Nathan W Zammit; Eleanor Self; Benno Postert; Jeremy Z R Han; Jacqueline Bailey; Joanna Warren; David R Croucher; Kazu Kikuchi; Ozren Bogdanovic; Tatyana Chtanova; Daniel Hesselson; Shane T Grey
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

Review 9.  A20: a master regulator of arthritis.

Authors:  Yongyao Wu; Xiaomin He; Ning Huang; Jiayun Yu; Bin Shao
Journal:  Arthritis Res Ther       Date:  2020-09-21       Impact factor: 5.156

Review 10.  COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.

Authors:  Christopher C Goodnow
Journal:  Immunol Cell Biol       Date:  2020-11-23       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.